INTERVIEW WITH PROF. TIMOTHY DEVOS
DAWN-PLASMA TRIAL AND THE USE OF CONVALESCENT PLASMA FOR COVID-19
In the past, the administration of convalescent plasma of persons having recovered from SARS and severe influenza to patients suffering from active disease showed promising effects on mortality and appeared safe. Whether or not this also holds true for the novel SARS-CoV-2 virus is currently unknown. A large scale trial, the DAWN-Plasma trial took place in Belgium to investigate this potential treatment. Professor Timothy Devos is co-first author of this trial… Read more
BHS COVID-19 REGISTRY
PRELIMINARY RESULTS OF THE BHS COVID-19 REGISTRY
The global COVID-19 pandemic has had a major impact on all the aspects of the healthcare system in Belgium, and haematology departments were no exception to this. In order to get more insights into the risk for severe COVID-19 infections among patients with haematological conditions, the Belgian Hematology Society (BHS) set up the BHS COVID-19 registry... Read more
INTERVIEW WITH CECILE OURY
‘OUR COVID ALGORITHM IS STILL UP-TO-DATE AND IN USE IN EVERY BELGIAN HOSPITAL’
In March 2020, the COVID-19 pandemic reached Belgium and threw the entire medical world in turmoil. For Professor Cécile Oury (research director F.R.S.-FNRS, head of the laboratory of Cardiology, GIGA-Cardiovascular unit at Liège University), who had only just been appointed president of the BSTH less than two months prior, it was a challenging time… Read more
INTERVIEW WITH ANNA ROUKENS
VACCINATING INTO SKIN INSTEAD OF MUSCLES COULD MEAN MANY MORE PEOPLE CAN BE IMMUNIZED
The current COVID-19 vaccination campaign involves injecting the vaccine into muscle tissue, but injecting a smaller amount of vaccine in the skin might also provide good protection. A crowdfunding campaign has enabled Dutch infectious disease specialist Anna Roukens MD, PhD, at the Leiden University Medical Centre (LUMC) to examine the safety and efficacy of vaccination delivery via the skin… Read more
Top
